Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<ul><li><keyword id="1672659" type="General" weightage="80" keywordseo="yatharth-hospital" source="Orion">Yatharth Hospital</keyword> is expected to announce its share allotment status today.</li><li>The shares of Yatharth Hospital were subscribed by 37.28 times overall.</li><li>The shares are expected to be listed on the stock exchanges on August 7.</li></ul> Yatharth Hospital and Trauma Care Services Limited, a multi-care hospital chain, is expected to announce the allotment status of its initial public offering (IPO) today, that is August 2. The <keyword id="13513381" type="General" weightage="80" keywordseo="yatharth-hospital-ipo" source="Orion">Yatharth Hospital IPO</keyword> opened on July 26 and closed on July 28. The price band for the IPO was ₹285 to ₹300 per share. <cmsannotation type="cmsannotation" annotationid="Decent subscription" comment="subhead" text="Decent subscription">Decent subscription</cmsannotation> On the last day, the Yatharth Hospital IPO was subscribed 37.28 times, receiving bids for 61.51 crore equity shares against 1.65 crore shares on offer. While the qualified institutional buyer portion was subscribed 86.37 times, the non-institutional investors portion was subscribed 38.62 times. The retail portion also witnessed decent participation and was subscribed 8.62 times. <cmsannotation type="cmsannotation" annotationid="Grey market premium" comment="subhead" text="Grey market premium">Grey market premium</cmsannotation> The shares of Yatharth Hospital are currently commanding a grey market premium (GMP) of ₹80 per share. GMP is the premium at which IPO shares are traded in an unofficial market before they are listed on the stock exchanges. <cmsannotation type="cmsannotation" annotationid="Here’s how to check the IPO’s allotment status" comment="subhead" text="Here’s how to check the IPO’s allotment status">Here’s how to check the IPO’s allotment status</cmsannotation> You can check the allotment status on the registrar’s website. <ul><li>To check the <keyword id="18228789" type="General" weightage="100" keywordseo="Yatharth-Hospital-IPO-allotment" source="Orion">Yatharth Hospital IPO allotment</keyword> status, visit the registrar’s website<a href="https://linkintime.co.in/IPO/public-issues.html"> here</a>.</li><li>Click on ‘Select Company’ and then select ‘Yatharth Hospital’.</li><li>Now, enter your PAN, application number, DP / Client ID or Account number / IFSC.</li><li>Now, enter the captcha.</li><li>Click on submit.</li></ul>You will be able to see your application status. It will display the number of shares that you have applied for and the number of shares that have been allotted to you. You can also check the Yatharth Hospital IPO allotment status on the BSE and NSE websites. To check the allotment status on BSE or NSE website: <ul><li>Go to the BSE<a href="https://www.bseindia.com/investors/appli_check.aspx"> website</a>.</li><li>On the website, click on 'Equity' and then select ‘Yatharth Hospital’ from the dropdown menu.</li><li>Now, enter your application number and PAN.</li><li>Click on 'Search'.</li></ul>You will be able to see the number of shares allotted to you. You can click<a href="https://www.nseindia.com/products-services/initial-public-offerings-bid-verification"> here</a> and log in to check your allotment status on NSE. Yatharth Hospital IPO listing date The shares of Yatharth Hospital will be listed on the stock exchanges on August 7. SEE ALSO: <a href="https://www.businessinsider.in/tech/mobile/news/indias-smartphone-shipments-continue-to-slip-but-premium-segment-going-strong-with-samsung-in-the-lead/articleshow/102300347.cms">India’s smartphone shipments continue to slip but premium segment going strong with Samsung in the lead</a> <a href="https://www.businessinsider.in/business/auto/news/cars-suvs-bikes-and-scooter-sales-number-in-july-2023/slidelist/102314290.cms">July auto sales: Maruti below estimates, Toyota records highest-ever show</a> <a href="https://www.businessinsider.in/tech/mobile/news/oneplus-nord-ce-3-5g-review-powerful-mid-ranger-with-sleek-design/articleshow/102300758.cms">OnePlus Nord CE 3 5G review – Powerful mid-ranger with sleek design</a>

Yatharth Hospital IPO allotment – How to check allotment status, listing date and more

<ul><li>The stock of Yatharth Hospitals listed at a premium of 1.3%, much below the grey market expectations. </li><li>The public issue of <keyword id="13515271" type="General" weightage="20" keywordseo="yatharth-hospital-trauma-care-services" source="Orion">Yatharth Hospital &amp; Trauma Care Services</keyword> was subscribed by 36 times the shares on offer. </li><li>The net proceeds will be utilised towards loan payments, capex, growth initiatives and general corporate purposes. </li></ul>Noida-based Yatharth Hospitals listed at ₹304 on the exchanges today, at a premium of 1.3%. The grey market had been hoping for a 20% premium above its IPO price of ₹300. The market cap of the company is at ₹2,609 crore as per data on BSE. The public issue was subscribed by 36 times the shares on offer. The retail portion of the issue was subscribed by 8.34 times, and non-institutional investors subscribed by 37.22 times. Qualified Institutional Buyers (QIBs) however bid aggressively on the third day of the issue, and this portion was subscribed 85 times. The public issue consists of fresh issue aggregating up to ₹490 crore and offer for sale of equity shares aggregating up to ₹197 crore. <table style="border-width: initial; border-style: none; table-layout: fixed; width: 468pt;"></colgroup><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Category </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">No of times subscribed </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">QIBs </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">85.1 </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Non institutional investors </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">37.22 </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Retail </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">8.34 </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Total </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">36.15 </td></tr></tbody></table>Source: BSE The company has fixed the price band for its equity shares at ₹285-300 per share. The net proceeds from the fresh issue will be utilised to repay or prepay borrowings, fund capex, towards funding inorganic growth initiatives through acquisitions and other strategic endeavours; and for general corporate purposes. Yatharth Hospital and Trauma Care Services is a multi-care hospital chain which was incorporated in 2008. It operates through its super specialty hospitals situated in Delhi NCR - Noida, Greater Noida, and Noida Extension, Uttar Pradesh. Its Noida Extension hospital has 450 beds and is one of the largest hospitals in the area. Further, they acquired a 305-bedded multi-specialty hospital in Orchha, Madhya Pradesh near Jhansi, which commenced operations in April 2022. Its total bed capacity is at 1405.

Yatharth Hospitals makes a tepid D-street debut listing at 1.3% premium

<ul><li>The retail portion of the issue was subscribed 8.3 times on day 2. </li><li>The QIB portion of the issue was subscribed 85 times over the shares on offer.</li><li>The net proceeds will be utilised to repay or prepay borrowings, fund capex, general corporate purposes and more. </li></ul>The public issue of <keyword id="13515271" type="General" weightage="20" keywordseo="yatharth-hospital-trauma-care-services" source="Orion">Yatharth Hospital &amp; Trauma Care Services</keyword> was subscribed by 36 times the shares on offer, on the last day of the issue. The retail portion of the issue was subscribed by 8.34 times, and non-institutional investors subscribed by 37.22 times. Qualified Institutional Buyers (QIBs) bid aggressively on the third day of the issue, and this portion was subscribed 85 times. The public issue consists of fresh issue aggregating up to ₹490 crore and offer for sale of equity shares aggregating up to ₹197 crore. The company has fixed the price band for its equity shares at ₹285-300 per share, allowing bids for a minimum of 50 equity shares and in multiples of 50 thereafter. The net proceeds from the fresh issue will be utilised to repay or prepay borrowings, fund capex, towards funding inorganic growth initiatives through acquisitions and other strategic endeavours; and for general corporate purposes. <table style="border-width: initial; border-style: none; table-layout: fixed; width: 468pt;" class="redcator-table-advance"></colgroup><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Category </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">No of times subscribed </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">QIBs </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">85.1 </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Non institutional investors </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">37.22 </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Retail </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">8.34 </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Total </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">36.15 </td></tr></tbody><tbody></tbody><tbody></tbody><tbody></tbody><tbody></tbody><tbody></tbody></table>Source: BSE About the company Yatharth Hospital and Trauma Care Services is a multi-care hospital chain which was incorporated in 2008. It operates through its super specialty hospitals situated in Delhi NCR - Noida, Greater Noida, and Noida Extension, Uttar Pradesh. Its Noida Extension hospital has 450 beds and is one of the largest hospitals in the area. It acquired a multi-specialty hospital in Orchha, Madhya Pradesh near Jhansi, which commenced operations in April 2022. The company's total bed capacity is now at 1405. Reasonable valuation, say broking firms “With healthy financials along with growth potentials in Northern India, we recommend ‘subscribe’ to the issue,” says a report by Nirmal Bang Securities. It believes that the issue is being offered at a reasonable valuation of 20.9x FY23 enterprise value/EBITDA as compared to its peers. “Considering its consistent topline growth, stable margins, strategic acquisition, revival of medical tourism, and promising industry outlook, we assign a ‘subscribe’ rating on a medium to long term basis,” says a note by Geojit. Canara Bank Securities however believes that there can’t be an apple-to-apple comparison with the hospital that’s concentrated in Delhi. “Majorly, their revenue contributes 34% from government deals which can stretch the debtor days and margin as well. Hence, we recommend subscribing to the issue for listing gains,” it said.

Yatharth Hospital & Trauma Care Services IPO subscribed 36x

New Delhi, Jul 20 <keyword id="13512899" type="General" weightage="20" keywordseo="Yatharth-Hospital-Trauma-Care" source="Orion">Yatharth Hospital &amp; Trauma Care</keyword> Ltd has set a price band of Rs 285-300 per share for its initial share sale, which will open for public subscription on July 26, according to market sources. The public issue will conclude on July 28 and the bidding for anchor investors will open on July 25, according to the red herring prospectus (RHP). The IPO comprises a fresh issue of equity shares aggregating up to Rs 490 crore and an offer-for-sale (OFS) of up to 65.51 lakh equity shares by the company's promoters and promoter group entities. The firm intends to utilize the net proceeds for repayment of debt, funding capital expenditure expenses, funding inorganic growth initiatives through acquisition and other strategic initiatives, and for general corporate purposes. At the upper end of the price band, the issue is expected to fetch Rs 687 crore and at the lower end Rs 677 crore. Half of the issue size has been reserved for qualified institutional investors, 35 per cent for retail investors and the remaining 15 per cent for non-institutional investors. Earlier this month, <keyword id="1672659" type="General" weightage="80" keywordseo="yatharth-hospital" source="Orion">Yatharth Hospital</keyword>, which operates and manages private hospitals in the Delhi-NCR region, raised Rs 120 crore from institutional investors. Those who participated in the pre-IPO round include Wealth Management LLP, Think India Opportunities Master Fund LP, and Rosy Blue Diamonds Pvt Ltd. This led to reduction in the fresh issue size to Rs 490 crore, from Rs 610 crore planned earlier. Intensive Fiscal Services Pvt Ltd, Ambit Pvt Ltd, and IIFL Securities Ltd are the book-running lead managers for the IPO.

Yatharth Hospital IPO to open on July 26, price band at ₹285-300

<ul><li>₹10 crore of the proceeds from the fresh issue will be used to repay or prepay certain borrowings availed by the company. </li><li>The current growth of the company has been aided by the geographical advantage of being located in Noida, Greater Noida and Noida Extension </li><li>The equity shares are being made available for purchase through the red herring prospectus of the company, dated July 18, 2023, which has been filed with the Registrar of Companies. </li></ul><keyword id="1672659" type="General" weightage="20" keywordseo="yatharth-hospital" source="Orion">Yatharth Hospital</keyword> and Trauma Care Services proposes to open its initial public offering (<keyword id="6354763" type="General" weightage="20" keywordseo="ipo" source="Orion">IPO</keyword>) of equity shares with a face value of ₹10 each on Wednesday, July 26, 2023. The IPO will consist of two components: a fresh issue of equity shares, amounting to ₹49 crore, and an offer for sale of up to 6,551,690 equity shares by existing selling shareholders (collectively known as the "Offer"). The anchor investor bidding date is scheduled for Tuesday, July 25, 2023. The subscription for the offer will open on Wednesday, July 26, 2023, and conclude on Friday, July 28, 2023. The company has fixed the price band for its equity shares at ₹285 to ₹300 per share, allowing bids for a minimum of 50 equity shares and in multiples of 50 thereafter. <cmsannotation type="cmsannotation" annotationid="How the funds from the IPO will be utilised" comment="subhead" text="How the funds from the IPO will be utilised">How the <keyword id="6356305" type="General" weightage="20" keywordseo="funds" source="Orion">funds</keyword> from the IPO will be utilised</cmsannotation> The net proceeds from the fresh issue will be utilized as follows: firstly, up to ₹10 crore will be used to repay or prepay certain borrowings availed by the company; secondly, up to ₹14.5 crore will go towards repaying or prepaying borrowings of its subsidiaries, AKS Medical and Research Centre and Ramraja Multispeciality Hospital and Trauma Centre, and thirdly, ₹2.56 crore will be allocated to fund the <keyword id="36749" type="General" weightage="20" keywordseo="capital" source="Orion">capital</keyword> expenditure expenses of Noida Hospital and Greater Noida Hospital. Also the company's subsidiaries, AKS and Ramraja, will receive up to ₹10.69 crore to support their respective hospital's capital expenditure expenses, and ₹6.5 crore is intended for funding inorganic growth initiatives through acquisitions and other strategic endeavors; and finally, the remaining balance will be utilised for general corporate purposes. The offer for sale consists of three categories of equity shares being offered by the promoter group sellings shareholders: up to 3,743,000 equity shares by Vimla Tyagi, up to 2,021,200 equity shares by Prem Narayan Tyagi, and up to 787,490 equity shares by Neena Tyagi. <cmsannotation type="cmsannotation" annotationid="The geographical advantage can be a double-edged sword" comment="subhead" text="The geographical advantage can be a double-edged sword">The geographical advantage can be a double-edged sword</cmsannotation> According to analysts at Axis Capital, the current growth of the company has been aided by the geographical advantage of being located in Noida, Greater Noida and Noida Extension. The Gautam Buddh Nagar district, the area in which their existing hospitals are situated, has witnessed strong economic growth in the last few years. These areas have developed rapidly in recent years on account of the growing real estate, economic development in these regions and increased purchasing power. Further, employment and capital invested in industries in these regions has been growing at a good rate, indicating potential for growth and economic activity. Being located in these regions allows them to serve patients from UP, Delhi, Haryana, Uttarakhand and other states as well. Their recent acquisition of the Jhansi-Orchha hospital is aimed at further expanding into new geographies and growing their presence in the regional healthcare market. However, as mentioned in the Red Herring Prospectus, this is also a potential risk. The company's operations are primarily concentrated in the Delhi NCR region. It heavily relies on certain specialties for a significant portion of its revenues. The financial performance of these hospitals and the earnings from its key specialties play a crucial role in shaping the overall business outcomes, financial condition, results of operations, and cash flows. Their ability to attract, retain, and train healthcare professionals, and operational, reputational, medical and legal claims, regulatory actions or other liabilities that could adversely affect their reputation and prospect have been identified among other risks. The equity shares are being made available for purchase through the red herring prospectus of the company, dated July 18, 2023, which has been filed with the Registrar of Companies, National Capital Territory of Delhi and Haryana. The plan is to have these shares listed on recognised stock exchanges, namely BSE Limited ("BSE") and the National Stock Exchange of India Limited ("NSE"). BSE has been designated as the specific stock exchange for the Offer.

Yatharth Hospital & Trauma Care IPO price band set at ₹285 to ₹300 per share – Key things to know

New Delhi, <keyword id="20609999" type="General" weightage="20" keywordseo="gpt-healthcare" source="keywords">GPT Healthcare</keyword> Ltd, which operates and manages mid-sized multi-specialty hospitals under the ILS Hospitals brand, on Monday fixed a price band at Rs 177-186 per share for its Rs 502-crore initial public offering (<keyword id="19898327" type="General" weightage="20" keywordseo="ipo" source="keywords">IPO</keyword>). The initial share-sale will open for a public subscription during February 22-26. The bidding for anchor investors will open for a day on February 21, the company said. The IPO is a combination of a fresh issue of equity shares aggregating to Rs 40 crore and an Offer For Sale (OFS) of up to 2.6 crore equity shares by private equity firm BanyanTree Growth Capital II. BanyanTree, which holds 2.6 crore shares or 32.64 per cent stake in Kolkata-based GPT Healthcare, is divesting its entire shareholding in the company. Proceeds from the fresh issue to the tune of Rs 30 crore will be used for payment of debt and general corporate purposes. At the upper end of the price, the IPO will mobilise Rs 501.67 crore. GPT Healthcare, founded by Dwarika Prasad Tantia, Dr Om Tantia and <keyword id="20641288" type="General" weightage="20" keywordseo="shree-gopal-tantia" source="keywords">Shree Gopal Tantia</keyword>, started with an eight-bed hospital in Kolkata in 2000. Today it operates four full service multi-specialty hospitals, with a total capacity of 561 beds. The company competes with listed industry peers, including Global Health Ltd, <keyword id="20641289" type="General" weightage="20" keywordseo="krishna-institute-of-medical-sciences-ltd" source="keywords">Krishna Institute of Medical Sciences Ltd</keyword>, <keyword id="20641290" type="General" weightage="20" keywordseo="jupiter-life-line-hospitals-ltd" source="keywords">Jupiter Life Line Hospitals Ltd</keyword>, Yatharth Hospital &amp; Trauma Care Services Ltd and Shalby Ltd. Investors can bid for a minimum of 80 equity shares and in multiples of 80 equity shares thereafter. Its total income increased 7.3 per cent to Rs 361.03 crore in FY23 from Rs 337.41 crore in FY22. JM Financial is the sole book-running lead manager to the issue. The equity shares are proposed to be listed on the BSE and the NSE.

GPT Healthcare sets IPO price band at ₹177-186 per share

Noida (UP), Jun 11 () Four more private hospitals will start treating COVID-19 patients in Gautam Buddh Nagar soon, adding to the existing 900 beds across Noida and Greater Noida for coronavirus cases, the district administration said on Thursday. The new hospitals are Fortis, Jaypee, Kailash and Yatharth, District Magistrate Suhas L Y said in a letter addressed to residents. These facilities will self-regulate the treatment cost, he said. At present, COVID-19 treatment is available at the Government Institute of Medical Sciences (GIMS), the District Hospital, the Noida Institute of Medical Sciences (NIMS) and private hospitals Sharda and Kailash. Responding in affirmative to a query asking if there were enough beds for COVID patients, Suhas said presently the district has around 250 active patients and the total capacity of beds is 900 -– 150 at GIMS, 50 at Child PGI, 400 at Sharda, 100 at Kailash and 200 at NIMS. "Hospitals namely Fortis, Jaypee, Kailash and Yatharth have submitted their proposals to the chief medical officer and will start functioning soon. They have been asked to self-regulate prices and publish the prices to the general public," he wrote, addressing a frequent query on the issue. Regarding non-COVID and emergency treatments, he said, "The Government and private hospitals are continuously trained, sensitised to follow laid down procedure and handle all such patients accordingly." He also spelled out two major challenges in fighting COVID-19– ensuring self-regulation and fighting misinformation. He appealed to the residents to remain aware and also help others regarding the Dos and Don'ts during the outbreak of the disease. He said while there is always a scope for improvement in delivery of services, a lot of time and energy of the health department is wasted in fighting misinformation. "The ultimate measure of a man is not where he stands in moments of comfort and convenience, but where he stands at times of challenge and adversity," Suhas signed off with a famous saying. Gautam Buddh Nagar, adjoining Delhi, in western Uttar Pradesh is one of the worst-hit districts in the state with 735 positive COVID-19 cases, including 11 deaths, so far, according to official figures. KIS TIR TIR

Noida: 4 more hospitals to start COVID-19 treatment soon

<ul><li>The stock made its debut at ₹210 as opposed to its IPO price of ₹108.</li><li>The grey market is expecting 60% listing gains from the stock.</li><li>The IPO was subscribed 97 times over the shares on offer. </li></ul>The stock of Mumbai-based Aeroflex Industries made its debut on the D-street at a 83% premium on Thursday. But soon after, the stock started slipping and ended 17% lower on debut day, paring off its listing gains. Its debut however was amongst the best in recent times, as it exceeded grey market expectations of a 60% premium. Its market cap is at ₹2,715 crore, as per data on Bombay Stock Exchange. The IPO was subscribed 97 times over the shares on offer on the last day of the issue. The grey market was expecting 60% listing gains from the stock. The IPO was subscribed 97 times over the shares on offer on the last day of the issue. Qualified institutional buyers (QIBs) bid aggressively as this portion was subscribed 194 times. Non-institutional investor portion was subscribed 126 times. The retail portion was subscribed 34 times the shares on offer. The company had also raised ₹103.68 crore from anchor investors like Societe Generale, Nippon Mutual Fund, Invesco Mutual Fund, White Oak Mutual Fund, BOI Mutual Fund, and more. The ₹351 crore initial public offer (IPO) is a combination of fresh issue and offer-for-sale (OFS) with promoters and other shareholders offloading stake via the share sale. The net proceeds of the fresh issue will be utilised towards full or part repayment and/or prepayment of outstanding borrowings; funding working capital requirements and for general corporate purposes and unidentified inorganic acquisitions. Listing gains of the last five market debuts While the market has seen a flurry of IPOs, the listing gains that they provided have been varied, with a few surprises and a few disappointments. <table style="border-width: initial; border-style: none; table-layout: fixed; width: 468pt;" class="redcator-table-advance"></colgroup><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Company </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Listing gains </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Pyramid Technoplast </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">12% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">TVS Supply Chain </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">5% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Concord Biotech </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">21% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">SBFC </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">43% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Yatharth Hospitals </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">1.3% </td></tr></tbody><tbody></tbody><tbody></tbody><tbody></tbody><tbody></tbody></table>About the company The company manufactures and supplies environmentally-friendly metallic flexible flow solution products to global as well as domestic markets from a single manufacturing facility in Taloja, Navi Mumbai. The flexible flow solutions include braided hoses, unbraided hoses, solar hoses, gas hoses, vacuum hoses, braiding, interlock hoses, hose assemblies, lancing hose assemblies, jacketed hose assemblies, exhaust connectors, exhaust gas recirculation (EGR) tubes and more. These solutions are used for transfer of substances be it air, liquid and solid — in any industrial or commercial ecosystem. They connect the origin and end points of various processes. For example, flow solution products are required in fire sprinklers, gas supply, fueling and hydraulics in aircrafts. The company has no listed peers in India, but the segment it operates in is fragmented and diversified. It can face competition from other large and small global and domestic players.

Aeroflex Industries slips on debut day after a stellar listing

IPO gold rush: All but 4 IPOs in FY24 gave positive returns on listing

<ul><li>Tata Technologies, Snapdeal, Fabindia and Navi Technologies are some of the most awaited IPOs of the season. </li><li>Around 13 companies filed their DRHPs between April to June 2023. </li><li>More tech, fintech and direct to consumer companies are expected to go public in the next two years.</li></ul>After a slow start in 2023, the <keyword id="6354763" type="General" weightage="20" keywordseo="ipo" source="Orion">IPO</keyword> market picked steam after the new financial year started in April. As many as 20 new companies listed on BSE and NSE, raising as much as ₹15,000 crore as of August. An IPO (Initial Public Offer) is the first sale of shares by a privately owned company to institutional and retail investors. Though it’s a far cry from ₹58,346 crore raised in 2022 — a lot of large and small companies alike have filed their draft red herring prospectus (DRHPs) with market regulator SEBI — promising an exciting year ahead. As per an E&amp;Y report, around 13 companies filed their DRHPs in April to June 2023, adding to the pipeline. Most active sectors in recent IPOs include hospitality &amp; construction, automotive &amp; transportation, diversified industrial products, and real estate. Apart from Rishabh Instruments’ ₹490 crore public offer and Ratnaveer Precision Engineering’s ₹165 crore public offers in the coming weeks, the stage has also been set for large companies looking to be listed. Amongst the most anticipated IPOs are Tata Technologies wherein Tata Motors is selling stake. This would be the first Tata company to go public in 19 years as the last company that was listed by the group is industry major TCS. <cmsannotation type="cmsannotation" annotationid="Upcoming IPOs" comment="subhead" text="Upcoming IPOs">Upcoming IPOs</cmsannotation> <table style="border-width: initial; border-style: none;" class="redcator-table-advance"></colgroup><tbody><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#000000;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Company </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#000000;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Amount </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Rishabh Instruments Limited </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹490.78 crore </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Ratnaveer Precision Engineering Limited </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹165.03 crore </td></tr></tbody><tbody></tbody><tbody></tbody><tbody></tbody><tbody></tbody><tbody></tbody><tbody></tbody><tbody></tbody><tbody></tbody></table><cmsannotation type="cmsannotation" annotationid="Companies who have filed their DRHP" comment="subhead" text="Companies who have filed their DRHP">Companies who have filed their DRHP</cmsannotation> Let’s look at some of the companies who have filed their DRHP and may soon announce their IPO - <ul><li>Navi Technologies</li><li>Tata Technologies</li><li>Balaji Speciality Chemicals</li><li>Snapdeal</li><li>Fabindia</li><li>NSDL</li><li>Imagine Marketing (boAt)</li></ul><cmsannotation type="cmsannotation" annotationid="Techs, fintechs &amp; more" comment="subhead" text="Techs, fintechs &amp; more">Techs, fintechs &amp; more</cmsannotation> New-age companies like Snapdeal filed their papers with the regulator and would be very watched due to the mixed reactions that Internet companies are continuing to receive. Moreover, it would be one the first large e-commerce companies to test the markets. Sachin Bansal’s Navi Technologies is another fintech company that will join the likes of Policybazaar, and household brand FabIndia has also refiled its papers. In spite of a lot of investor concern around new-age companies, experts believe that India will see a lot of tech IPOs in the coming years. Mamaearth’s parent Honasa Consumer has also received a nod from SEBI for their IPO, even though it was delayed as of March this year. “By FY25, India is likely to have up to 40 listed/IPO ready new-age companies, which can grow to 90 by FY28. SaaS, B2C Product Companies, and FinTech are amongst the most promising categories to produce IPO-ready companies," Rohan Agarwal, partner at Redseer said in a recent report. These companies, Agarwal believes, have sizable revenues, sustainable growth, a strong EBITDA, and operate on defensible business models, making them strong candidates for IPO. Another Solapur based specialty chemicals company Balaji Specialty Chemicals also hopes to add to the many companies that have provided outsized returns to their investors in the last few years — as the sector is on an upcycle. "India's current IPO market trend showcases its immense potential and has witnessed a remarkable surge in recent years. In the forthcoming months, there is anticipated to be significant momentum in the Indian IPO market, encompassing both the main and SME market segments," said Adarsh Ranka, partner, financial accounting advisory services leader, network firm of EY Global. <cmsannotation type="cmsannotation" annotationid="Fundraising in 2023" comment="subhead" text="Fundraising in 2023">Fundraising in 2023</cmsannotation> <table style="border-width: initial; border-style: none;"></colgroup><tbody><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#000000;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Company </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#000000;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Funds raised in 2023 </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Vishnu Prakash R Punglia </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹309 crore </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Aeroflex Industries </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹351 crore </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Pyramid Technoplast </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹153 crore </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">TVS Supply Chain </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹880 crore </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Concord Biotech </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹1,551 crore </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">SBFC Finance </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹1,025 crore </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Yatharth Hospital </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹686 crore </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Netweb Technologies </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹631 crore </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Utkarsh Small Finance Bank </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹500 crore </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Senco Gold </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹405 crore </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Cyient DLM </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹592 crore </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Ideaforge Technologies </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹567 crore </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">HMA Agro </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹480 crore </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">IKIO Lighting </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹606 crore </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Divgi TorqTransfer </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹412 crore </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Global Surface </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹155 crore </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Udayshivkumar Infra </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹66 crore </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Mankind Pharma </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;background-color:#d9d9d9;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹4,326 crore </td></tr><tr><td style="border-left:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Avalon Technologies </td><td style="border-right:solid #000000 0.6260872500000001pt;border-bottom:solid #000000 0.6260872500000001pt;border-top:solid #000000 0.6260872500000001pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹865 crore </td></tr></tbody></table>

IPOs galore – India’s primary market to remain buzzing in 2023

Noida (UP), Jun 12 () There are eight sample collection centres for COVID-19 testing in Noida and Greater Noida and residents can use a dedicated helpline for appointment, officials in Gautam Buddh Nagar said on Friday. The helpline number is 18004192211, the officials said. In Noida, the collection centres are at the District Hospital in Sector 30, the new district hospital building in Sector 39, the Community Health Care Centre in Bhangel, District Surveillance Officer Sunil Dohare said. In Greater Noida, the centres are at primary health care centres at Bisrakh, Dankaur and Jewar and the CHC in Dadri, besides the Government Institute of Medical Sciences (GIMS), he added. He said the protocols with regard to the accredited labs and selection of persons who are tested for COVID-19 is decided by the Indian Council for Medical Research (ICMR). "All primary high-risk contacts and such persons exhibiting influenza-like illness (ILI) symptoms and other categories of persons (including random sampling) are sampled and tested through the COVID labs," Dohare said in a statement. "To make the experience seamless, we have dedicated special team of doctors who will ascertain your requirements, and get the testing schedule as per protocol. All people need to do is dial 18004192211 and press option 1 and provide their requirements after which the doctors will call and give time and date for sampling," he said. District Magistrate Suhas L Y on Thursday said that 900 beds are available in Gautam Buddh Nagar across dedicated government and private facilities for COVID-19 patients. Responding in affirmative to a query on adequate beds for COVID patients, DM Suhas said presently around 250 patients are active in the district and total capacity of beds is 900 – 150 at GIMS, 50 at Child PGI, 400 at Sharda, 100 at Kailash and 200 at NIMS. At present, COVID-19 treatment is available at the Government Institute of Medical Sciences (GIMS), the District Hospital, the Noida Institute of Medical Sciences (NIMS) and private hospitals Sharda and Kailash. The DM said four new private hospitals -- Fortis, Jaypee, Kailash and Yatharth – will soon start functioning for COVID-19 treatment, but they will self-regulate the treatment cost. Gautam Bddh Nagar, adjoining Delhi, in western Uttar Praesh has so far recorded 830 positive cases of coronavirus, including 12 deaths, according to official figures. KIS TIR TIR

You Searched For "yatharth hospital" and got 11 results

Yatharth Hospital IPO allotment – How to check allotment status, listing date and more

Sourabh Jain

Yatharth Hospitals makes a tepid D-street debut listing at 1.3% premium

Katya Naidu

Yatharth Hospital & Trauma Care Services IPO subscribed 36x

Katya Naidu

Yatharth Hospital IPO to open on July 26, price band at ₹285-300

PTI

Yatharth Hospital & Trauma Care IPO price band set at ₹285 to ₹300 per share – Key things to know

Anagh Pal

GPT Healthcare sets IPO price band at ₹177-186 per share

PTI

Noida: 4 more hospitals to start COVID-19 treatment soon

PTI

Aeroflex Industries slips on debut day after a stellar listing

Katya Naidu

IPO gold rush: All but 4 IPOs in FY24 gave positive returns on listing

Katya Naidu

IPOs galore – India’s primary market to remain buzzing in 2023

Sourabh

Katya

Noida: Dial 18004192211 for scheduling COVID-19 test

PTI

Popular Keywords

Buying Guides